Replies to post #11774 on PuraMed BioScience, Inc. (fka PMBS)

[vans]

As per latest filing(page 19 bottom and page 20)
IF YOU HAVE DONE ANY DD YOU WOULDNT BE ASKING THESE QUESTIONS
www.otcmarkets.com/edgar/GetFilingPdf?FilingID=9796320

Continuation of Product Development
–
Besides its already developed products, PuraMed will complete development and testing of additional
non-prescription drugs and nutritional supplements
to be commercially launched in the future as additional LipiGesic® products.

Assuming the Company raises the capital, we anticipate spending approximately $3,000,000 million over
the next twelve months on the marketing of our migraine headache remedy along with the introduction of our second product offering regardless of any amounts of revenues
we generate from product sales during this period.
These funds will be spent as follows:


Sales and marketing expenses
$
2,000,000

Purchase of product inventory, packaging and raw ma
terials
600,000

Research and development activities
100,000

General and administrative expenses including rent,
fixed overhead and management compensation
300,000